Pink Sheet Podcast: Trump’s Potential Impact On FDA User Fees, Dr. Oz’s Potential Impact On CMS

Pink Sheet reporter and editors discuss concerns that the incoming administration could try to influence the upcoming FDA user fee reauthorization, as well as the changes Dr. Mehmet Oz, President-elect Donald Trump’s controversial selection to run the US Centers for Medicare and Medicaid Services, could impose if confirmed.